In addition, current diagnostic approaches are inadequate, in particular, prostate-specific antigen (PSA) is a prostate, but not cancer, specific biomarker, and repeated biopsies are required to distinguish between benign prostate hyperplasia (BPH) and PCa [22]. This evidence concerns the gene KLK3 and cancer.